Skip to main content
Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
1.320
-0.100 (-7.04%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Aadi Bioscience Revenue

Aadi Bioscience had revenue of $23.84M in the twelve months ending March 31, 2024, with 26.97% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.35M, a -8.76% decrease year-over-year. In the year 2023, Aadi Bioscience had annual revenue of $24.35M with 60.06% growth.

Revenue (ttm)
$23.84M
Revenue Growth
+26.97%
P/S Ratio
1.36
Revenue / Employee
$317,867
Employees
75
Market Cap
32.41M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M--
Dec 31, 20190--
Dec 31, 201820.16M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortress Biotech 85.11M
Retractable Technologies 40.20M
ImmuCell 21.28M
DarioHealth 19.04M
IceCure Medical 3.26M
Revenue Rankings

AADI News

More News